// App-Quantinova.ai

16923 : The Impact of the Publication of Cardiovascular Safety Signals on the Prescribing of Varenicline: an Interrupted Time-Series Analysis

Researchers

Presenter

  • Maria Eberg

Principal Investigators

  • Laurent Azoulay

Medical Centers

  • McGill Univ, Jewish General Hosp, Lady Davis Inst for Medical Res, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Champix

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim